David Arkowitz

Insider Reports History

Entity
Individual
Location
C/O Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington, MA
Signature
/s/ Nanette Agustines, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Arkowitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Chief Financial Officer Common Stock 221K $1.88M $8.50 May 10, 2021 Direct
Seres Therapeutics, Inc. Chief Financial Officer Common Stock 182K $197K $1.08 Feb 16, 2024 Direct
Seres Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 31.9K $43K $1.35 Feb 15, 2024 Direct
Seres Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 288K Feb 14, 2024 Direct
KINETA, INC./DE Director Stock Option (Right to Buy) 12.5K Sep 4, 2024 Direct
F-star Therapeutics, Inc. Director Common Stock 0 $7.12 Mar 8, 2023 Direct
F-star Therapeutics, Inc. Director Warrant (right to buy) 0 Nov 20, 2020 Direct

Insider Reports Filed by David Arkowitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KA KINETA, INC./DE Sep 4, 2024 1 $0 4 Sep 5, 2024 Director
MCRB Seres Therapeutics, Inc. Feb 14, 2024 6 -$4.25K 4 Feb 16, 2024 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Oct 27, 2023 4 -$5.49K 4 Oct 31, 2023 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Apr 27, 2023 1 $0 4 May 1, 2023 Chief Financial Officer
KA KINETA, INC./DE Apr 12, 2023 2 $0 4 Apr 14, 2023 Director
MCRB Seres Therapeutics, Inc. Feb 3, 2023 2 $0 4 Feb 7, 2023 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Jul 5, 2022 1 $200K 4 Jul 6, 2022 Chief Financial Officer
FSTX F-star Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 15, 2022 3 $0 4 Oct 31, 2022 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Feb 4, 2022 1 $0 4 Feb 8, 2022 Executive Vice President, Chief Financial Officer and Head of Business Development
FSTX F-star Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
KA YUMANITY THERAPEUTICS, INC. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
MCRB Seres Therapeutics, Inc. Jun 1, 2021 2 $0 4 Jun 1, 2021 Chief Financial Officer
MCRB Seres Therapeutics, Inc. Jun 1, 2021 0 $0 3 Jun 1, 2021 Chief Financial Officer
FLXN Flexion Therapeutics Inc May 10, 2021 1 -$16.1K 4 May 12, 2021 Chief Financial Officer
FSTX F-star Therapeutics, Inc. Nov 20, 2020 10 -$59.7K 4 Mar 9, 2023 Director